These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3193442)

  • 1. A serogrouping scheme for the study of the epidemiology of Bacteroides fragilis.
    Elhag KM; Senthilselvan A
    J Med Microbiol; 1988 Nov; 27(3):199-205. PubMed ID: 3193442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serogrouping of Bacteroides fragilis subsp. fragilis by the agglutination test.
    Lambe DW; Moroz DA
    J Clin Microbiol; 1976 Jun; 3(6):586-92. PubMed ID: 950378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The distribution of Bacteroides fragilis serotypes amongst clinical strains.
    Elhag KM; Tabaqchali S
    J Hyg (Lond); 1978 Aug; 81(1):89-97. PubMed ID: 690426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological aspects of infections caused by Bacteroides fragilis and Clostridium difficile.
    Tabaqchali S; Wilks M
    Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1049-57. PubMed ID: 1295758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the antigenic composition of the fragilis group of Bacteroides.
    Elhag KM; Alkarmi TO
    J Med Microbiol; 1991 Aug; 35(2):118-22. PubMed ID: 1875392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological studies of Bacteroides fragilis.
    Elhag KM; Bettelheim KA; Tabaqchali S
    J Hyg (Lond); 1977 Oct; 79(2):233-41. PubMed ID: 269199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of the Bacteroides fragilis group in the colonic flora in 10 patients with colonic cancer.
    Namavar F; Theunissen EB; Verweij-Van Vught AM; Peerbooms PG; Bal M; Hoitsma HF; MacLaren DM
    J Med Microbiol; 1989 Jul; 29(3):171-6. PubMed ID: 2746627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic characteristics of enterotoxigenic and nonenterotoxigenic isolates of Bacteroides fragilis.
    Myers LL; Shoop DS
    Am J Vet Res; 1987 Apr; 48(4):643-5. PubMed ID: 3109288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of enterotoxigenic Bacteroides fragilis in hospital-acquired diarrhea.
    Cohen SH; Shetab R; Tang-Feldman YJ; Sarma P; Silva J; Prindiville TP
    Diagn Microbiol Infect Dis; 2006 Aug; 55(4):251-4. PubMed ID: 16650957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serogrouping of Bacteroides vulgatus by the agglutination test.
    Okamura N; Miyazaki K; Chida T; Niwayama K; Nakaya R; Benno Y; Mitsuoka T
    J Clin Microbiol; 1985 Jul; 22(1):56-61. PubMed ID: 4019743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of intestinal and extra-intestinal strains of enterotoxigenic Bacteroides fragilis by the HT-29 cytotoxicity assay.
    Pantosti A; Cerquetti M; Colangeli R; D'Ambrosio F
    J Med Microbiol; 1994 Sep; 41(3):191-6. PubMed ID: 8064839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of bft gene subtypes in Bacteroides fragilis clinical isolates.
    Avila-Campos MJ; Liu C; Song Y; Rowlinson MC; Finegold SM
    J Clin Microbiol; 2007 Apr; 45(4):1336-8. PubMed ID: 17301286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serogrouping of Bacteroides nodosus isolates from 62 sources in the United States.
    Gradin JL; Sonn AE; Petrovska L
    Am J Vet Res; 1993 Jul; 54(7):1069-73. PubMed ID: 8368601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid identification of clinically important bacteroides by coagglutination method.
    Lalitha MK; Anandi V; Elias L; Kalpana CR
    Indian J Med Res; 1991 Mar; 93():98-102. PubMed ID: 1855827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of antibiotic resistance genes in Bacteroides fragilis group strains isolated in different European countries.
    Eitel Z; Sóki J; Urbán E; Nagy E;
    Anaerobe; 2013 Jun; 21():43-9. PubMed ID: 23500457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difficulties in the serodiagnosis of infection with the fragilis group of Bacteroides.
    Elhag KM; Bahar AM; Mahajan KK
    J Med Microbiol; 1987 Sep; 24(2):125-31. PubMed ID: 3309321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
    Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
    Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to detect capsular diversity among Bacteroides fragilis isolates.
    Pantosti A; Colangeli R; Tzianabos AO; Kasper DL
    J Clin Microbiol; 1995 Oct; 33(10):2647-52. PubMed ID: 8567899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capsular and 'O' serotype determinants of bacteroides fragilis.
    Tabaqchali S; Fiddian PA; El-Hag K; Kasper DL
    Infection; 1982; 10(6):333-7. PubMed ID: 6185437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-infection due to imipenem-resistant Bacteroides fragilis associated with a totally implantable venous port.
    Arpin C; Dubois V; Rogues AM; Menard F; Gavinet AM; Maire JP; Gachie JP; Bezian MC; Quentin C
    J Clin Microbiol; 2002 Aug; 40(8):3032-4. PubMed ID: 12149371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.